fbpx Right tools for the job: diagnosing bipolar I (Part 2) | Progress In Mind

Right tools for the job: diagnosing bipolar I (Part 2)

The right tools

Detecting mania with depressive symptoms

 

One area within bipolar I which tends to be particularly undiagnosed and at the same time a high risk episode for patients, is the mixed state of mania with depressive symptoms.

Manic episodes with depressive symptoms are generally more severe and are associated with a poorer prognosis than pure manic episodes. Although these states are common, they are not easily identified by clinicians.3,4

The DSM-5, includes a new 'With Mixed Features’ specifier for hypomanic, manic or depressive episodes episodes.5 For hypomanic and manic episodes, at least three of six depressive symptoms must be present to allocate the specifier.6 To complement this, a new module of the Mini International Neuropsychiatric Interview (M.I.N.I.) has also been developed to enable patient self-evaluation for the DSM-5 specifier. You can click here for a copy of the M.I.N.I.

 

Mini International Neuropsychiatric Interview (M.I.N.I.)

 

Presenting a poster on detecting depressive symptoms in mania at the 27th ECNP in Berlin last year, Professor Allan Young talked about the new module which he helped to develop.

“About 30-35% of people with mania will have significant depressive symptoms but we’re not very good at picking it up. This structured tool should help that. In addition, we correlated with other symptoms and it seems as though the depressive symptoms are particularly likely to flag up patients who have mania symptoms, irritability, agitation, and anxiety symptoms. This is important because this group is disproportionately vulnerable in terms of health outcomes; they tend to stay in hospital longer, they have poorer outcomes and they have higher suicide and attempted suicide rates. So this is a tool to help clinicians identify and hopefully treat better this vulnerable group of patients.”

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References

1. N Craddock, P Sklar. The Lancet 2013; 381: 1654-1662
2. "International Classification of Diseases (ICD)". World Health Organization.
3. Gonzalez-Pinto, et al. CNS Drugs 2007; 21: 611-626
4. McElroy, et al. AM J Psychiatry 1992; 149:1633-1644
5. American Psychiatric Asociation. Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5). American Psychiatric Association, 2013
6. Young A and Eberhard J. Poster presented at the International Society of Affective Disorders (ISAD) Congress, 28th – 30th April 2014, Berlin, Germany.

You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country